Skip to main content
Clinical Trials/ACTRN12612000350820
ACTRN12612000350820
Terminated
未知

A Multicentre Prospective Observational Study on the Safety and Efficacy of High Frequency Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients

evro Corporation0 sites50 target enrollmentMarch 27, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
evro Corporation
Enrollment
50
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 27, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
evro Corporation

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with CRPS according to the Budapest research diagnostic criteria
  • Symptoms for more than 6 months and less than 5 years
  • Failed conservative management for 3 months
  • Average pain intensity of at least 5cm out of 10cm in the 30 days prior to the Baseline Visit (based on the baseline visit VAS)
  • Over 18 years of age
  • Able to provide informed consent and willing to comply with study procedures

Exclusion Criteria

  • Contra\-indication to the implantation of an SCS system
  • Medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures, accurate pain reporting, and/or confound evaluation of study endpoints
  • Have a current diagnosis of a progressive neurological disease such as multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, rapidly progressive arachnoiditis, rapidly progressive diabetic peripheral neuropathy, brain or spinal cord tumor, or severe/critical spinal stenosis
  • Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention and/or ability to evaluate treatment outcome as determined by a psychiatrist
  • Female patients that are pregnant or are planning to become pregnant over the next 12 months
  • Life expectancy of lesss than 1 year
  • Inability to manage the technical demands of the SCS equipment

Outcomes

Primary Outcomes

Not specified

Similar Trials